BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 38097860)

  • 21. Zapped assembly of polymeric (ZAP) nanoparticles for anti-cancer drug delivery.
    Dunn SS; Luft JC; Parrott MC
    Nanoscale; 2019 Jan; 11(4):1847-1855. PubMed ID: 30637420
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and evaluation of polymeric micelle containing piperacillin/tazobactam for enhanced antibacterial activity.
    Morteza M; Roya S; Hamed H; Amir Z; Abolfazl A
    Drug Deliv; 2019 Dec; 26(1):1292-1299. PubMed ID: 31797692
    [TBL] [Abstract][Full Text] [Related]  

  • 23. RETRACTED: Enhanced antitumor efficacy of 5-fluorouracil loaded methoxy poly(ethylene glycol)-poly(lactide) nanoparticles for efficient therapy against breast cancer.
    Yuan Z; Qu X; Wang Y; Zhang DY; Luo JC; Jia N; Zhang ZT
    Colloids Surf B Biointerfaces; 2015 Apr; 128():489-497. PubMed ID: 25779606
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functionalized phosphorylated cellulose microspheres: Design, characterization and ciprofloxacin loading and releasing properties.
    Wu S; Gong Y; Liu S; Pei Y; Luo X
    Carbohydr Polym; 2021 Feb; 254():117421. PubMed ID: 33357902
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Holistic Study Design Following Quality by Design Approach for Fabrication of Hybrid Polymeric Nanoparticulate Based Dry Powders as Carriers for Ciprofloxacin.
    Ambrus R; Csóka I; Fenyes E; Orosz L; Sarkadi ÁN; Burián K; Kókai D; Mukhtar M
    J Pharm Sci; 2024 Jul; 113(7):1946-1959. PubMed ID: 38643899
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preparation of Drug-Loaded PLGA-PEG Nanoparticles by Membrane-Assisted Nanoprecipitation.
    Albisa A; Piacentini E; Sebastian V; Arruebo M; Santamaria J; Giorno L
    Pharm Res; 2017 Jun; 34(6):1296-1308. PubMed ID: 28342057
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preparation, evaluation, and
    Pan X; Liu S; Ju L; Xi J; He R; Zhao Y; Zhuang R; Huang J
    Drug Dev Ind Pharm; 2020 Nov; 46(11):1889-1897. PubMed ID: 32975456
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preparation of PLGA-chitosan based nanocarriers for enhancing antibacterial effect of ciprofloxacin in root canal infection.
    Arafa MG; Mousa HA; Afifi NN
    Drug Deliv; 2020 Dec; 27(1):26-39. PubMed ID: 31833443
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimization of ciprofloxacin complex loaded PLGA nanoparticles for pulmonary treatment of cystic fibrosis infections: Design of experiments approach.
    Günday Türeli N; Türeli AE; Schneider M
    Int J Pharm; 2016 Dec; 515(1-2):343-351. PubMed ID: 27744035
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Surface-modified PLGA nanoparticles with PEG/LA-chitosan for targeted delivery of arsenic trioxide for liver cancer treatment: Inhibition effects enhanced and side effects reduced.
    Song X; Wang J; Xu Y; Shao H; Gu J
    Colloids Surf B Biointerfaces; 2019 Aug; 180():110-117. PubMed ID: 31030022
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Release of adriamycin from poly(lactide-co-glycolide)-polyethylene glycol nanoparticles.
    Mo SM; Oh IJ
    J Nanosci Nanotechnol; 2011 Feb; 11(2):1795-8. PubMed ID: 21456294
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polysaccharide-modified nanoparticles with intelligent CD44 receptor targeting ability for gene delivery.
    Lin WJ; Lee WC
    Int J Nanomedicine; 2018; 13():3989-4002. PubMed ID: 30022822
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sustained release of antimicrobials from double-layer nanofiber mats for local treatment of periodontal disease, evaluated using a new micro flow-through apparatus.
    Zupančič Š; Casula L; Rijavec T; Lapanje A; Luštrik M; Fadda AM; Kocbek P; Kristl J
    J Control Release; 2019 Dec; 316():223-235. PubMed ID: 31669567
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ocular disposition of ciprofloxacin from topical, PEGylated nanostructured lipid carriers: Effect of molecular weight and density of poly (ethylene) glycol.
    Balguri SP; Adelli GR; Janga KY; Bhagav P; Majumdar S
    Int J Pharm; 2017 Aug; 529(1-2):32-43. PubMed ID: 28634139
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Maleimide-functionalised PLGA-PEG nanoparticles as mucoadhesive carriers for intravesical drug delivery.
    Kaldybekov DB; Filippov SK; Radulescu A; Khutoryanskiy VV
    Eur J Pharm Biopharm; 2019 Oct; 143():24-34. PubMed ID: 31419584
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PEG-PLGA copolymers: their structure and structure-influenced drug delivery applications.
    Zhang K; Tang X; Zhang J; Lu W; Lin X; Zhang Y; Tian B; Yang H; He H
    J Control Release; 2014 Jun; 183():77-86. PubMed ID: 24675377
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Use of an Efficient Microfluidic Mixing System for Generating Stabilized Polymeric Nanoparticles for Controlled Drug Release.
    Morikawa Y; Tagami T; Hoshikawa A; Ozeki T
    Biol Pharm Bull; 2018; 41(6):899-907. PubMed ID: 29863078
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biodegradable nano-architectural PEGylated approach for the improved stability and anticancer efficacy of bendamustine.
    Khan I; Gothwal A; Sharma AK; Qayum A; Singh SK; Gupta U
    Int J Biol Macromol; 2016 Nov; 92():1242-1251. PubMed ID: 27527691
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tacrolimus-loaded methoxy poly(ethylene glycol)-block-poly(D,L)-lactic-co-glycolic acid micelles self-assembled in aqueous solution for treating cornea immune rejection after allogenic penetrating keratoplasty in rats.
    Liu D; Wu Q; Chen W; Lin H; Liu Y; Liang H; Zhu F
    Eur J Pharm Sci; 2019 May; 133():104-114. PubMed ID: 30928512
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Imipenem/cilastatin encapsulated polymeric nanoparticles for destroying carbapenem-resistant bacterial isolates.
    Shaaban MI; Shaker MA; Mady FM
    J Nanobiotechnology; 2017 Apr; 15(1):29. PubMed ID: 28399890
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.